INS and diabetes mellitus: Finally, the prevalence of remission of diabetes after 3-months washout did not differ significantly between these three insulin-based interventions (Glar/Exenatide 26.7%, Glar/Lispro 43.8%, Glar 32.1%; p = 0.35; Fig. 5B).